Company Overview of Synthetic Biologics Inc.
Mark Wilcox M.D., FRCPath
Chairman of C Difficile Clinical Advisory Board, Synthetic Biologics Inc.
|Age||Total Calculated Compensation||This person is connected to 5 Board Members in 5 different organizations across 5 different industries.|
See Board Relationships
Dr. Mark Wilcox, M.D., FRCPath, serves as a Consultant Microbiologist, Head & Professor of Medical, and Academic Lead of Pathology/Clinical Director of Pathology, at the Leeds Teaching Hospitals (LTHT). Dr. Wilcox is a Professor of Medical Microbiology at the University of Leeds at their Institute of Biomedical and Clinical Sciences, and is the lead on Clostridium difficile for Public Health England in the UK. Dr. Wilcox serves as the Principal/UK Investigator for several ...
9605 Medical Center DrivePhone: 301-417-4364
Rockville, Maryland 20850
Board Members MembershipsThere is no Board Members Memberships data available.
EducationThere is no Education data available.
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Request Profile Update
Only a company representative may request an update for the company profile. Documentation will be required.
Please enter your information in the following field(s):